QT
LYEL icon

Quantbot Technologies’s Lyell Immunopharma LYEL Stock Holding History

Quantbot Technologies’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-115
Closed -$5.43K – 1793
2023
Q1 		$5.43K Buy
+115
New +$6.15K ﹤0.01% 1435
2022
Q4 		– Sell
-5
Closed – – 1929
2022
Q3 		$0 Sell
5
-125
-96% -$16.9K ﹤0.01% 1873
2022
Q2 		$16K Buy
+130
New +$13.3K ﹤0.01% 1475

Other funds holding LYEL

MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return

Quantbot Technologies's LYEL Position: Q2 2023 in Review

Quantbot Technologies sold out of Lyell Immunopharma (LYEL) in Q2 2023, closing a stake of 115 shares — an estimated $5.43K sold.

Quantbot Technologies first reported a position in LYEL in Q2 2022 and held it in 3 quarters. The position peaked at $16K in Q2 2022. 99 funds tracked by Wall St. Rank hold LYEL as of Q2 2023.

  • Quantbot Technologies reported no remaining Lyell Immunopharma position as of Q2 2023 after selling out during the quarter.
  • Quantbot Technologies sold 115 Lyell Immunopharma shares in Q2 2023, an estimated $5.43K.
  • Quantbot Technologies first reported a position in Lyell Immunopharma in Q2 2022 and held it in 3 quarters.
  • Quantbot Technologies's Lyell Immunopharma position peaked at $16K in Q2 2022.
  • 99 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2023.

Based on Quantbot Technologies's 13F filing for Q2 2023, filed 8 Aug 2023.